Works matching IS 13866346 AND DT 2019 AND VI 49 AND IP 5

Results: 13

Emerging novel treatments for autoimmune liver diseases.

Published in:

Hepatology Research, 2019, v. 49, n. 5, p. 489, doi. 10.1111/hepr.13347

By:

Tanaka, Atsushi

Publication type:

Article

Issue Information.

Published in:: Hepatology Research, 2019, v. 49, n. 5, p. 487, doi. 10.1111/hepr.13340
Publication type:: Article

Full‐genome characterization of the RIVM‐HAV16‐090‐like hepatitis A virus strains recovered from Japanese men who have sex with men, with sporadic acute hepatitis A.

Published in:

Hepatology Research, 2019, v. 49, n. 5, p. 521, doi. 10.1111/hepr.13313

By:

Watanabe, Shunji;
Morimoto, Naoki;
Miura, Kouichi;
Takaoka, Yoshinari;
Nomoto, Hiroaki;
Tsukui, Mamiko;
Isoda, Norio;
Ohnishi, Hiroshi;
Nagashima, Shigeo;
Takahashi, Masaharu;
Okamoto, Hiroaki;
Yamamoto, Hironori

Publication type:

Article

Utility of ultrasound‐guided liver tumor biopsy for next‐generation sequencing‐based clinical sequencing.

Published in:

Hepatology Research, 2019, v. 49, n. 5, p. 579, doi. 10.1111/hepr.13312

By:

Eso, Yuji;
Kou, Tadayuki;
Nagai, Hiroki;
Kim, Young Hak;
Kanai, Masashi;
Matsumoto, Shigemi;
Mishima, Masako;
Arasawa, Soichi;
Iguchi, Eriko;
Nakamura, Fumiyasu;
Takeda, Haruhiko;
Takai, Atsushi;
Takahashi, Ken;
Ueda, Yoshihide;
Muto, Manabu;
Seno, Hiroshi

Publication type:

Article

Influence of renal dysfunction on dose reduction and virologic efficacy of regimens combining ribavirin and all‐oral direct acting antivirals in patients with chronic hepatitis C virus infection.

Published in:

Hepatology Research, 2019, v. 49, n. 5, p. 512, doi. 10.1111/hepr.13311

By:

Nakashima, Megumi;
Toyoda, Hidenori;
Tada, Toshifumi;
Mizuno, Kazuyuki;
Iio, Etsuko;
Tanaka, Yasuhito;
Sugiyama, Tadashi;
Yoshimura, Tomoaki;
Kumada, Takashi

Publication type:

Article

Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response.

Published in:

Hepatology Research, 2019, v. 49, n. 5, p. 570, doi. 10.1111/hepr.13310

By:

Yamada, Ryoko;
Hiramatsu, Naoki;
Oze, Tsugiko;
Urabe, Ayako;
Tahata, Yuki;
Morishita, Naoki;
Kodama, Takahiro;
Hikita, Hayato;
Sakamori, Ryotaro;
Yakushijin, Takayuki;
Yamada, Akira;
Hagiwara, Hideki;
Mita, Eiji;
Oshita, Masahide;
Itoh, Toshifumi;
Fukui, Hiroyuki;
Inui, Yoshiaki;
Hijioka, Taizo;
Inada, Masami;
Katayama, Kazuhiro

Publication type:

Article

Oncogenic role of phospholipase C‐γ1 in progression of hepatocellular carcinoma.

Published in:

Hepatology Research, 2019, v. 49, n. 5, p. 559, doi. 10.1111/hepr.13309

By:

Tang, Wenqing;
Zhou, Yi;
Sun, Dalong;
Dong, Ling;
Xia, Jinglin;
Yang, Biwei

Publication type:

Article

Risk factors for loss of skeletal muscle mass in patients with cirrhosis.

Published in:

Hepatology Research, 2019, v. 49, n. 5, p. 550, doi. 10.1111/hepr.13308

By:

Sung, Ji Hyun;
Uojima, Haruki;
Hidaka, Hisashi;
Tanaka, Yoshiaki;
Wada, Naohisa;
Kubota, Kousuke;
Nakazawa, Takahide;
Shibuya, Akitaka;
Fujikawa, Tomoaki;
Yamanoue, Hiroki;
Kako, Makoto;
Koizumi, Wasaburo

Publication type:

Article

Association of serum interferon‐λ3 levels with hepatocarcinogenesis in chronic hepatitis C patients treated with direct‐acting antiviral agents.

Published in:

Hepatology Research, 2019, v. 49, n. 5, p. 500, doi. 10.1111/hepr.13307

By:

Inoue‐Shinomiya, Emi;
Murakawa, Miyako;
Asahina, Yasuhiro;
Nakagawa, Mina;
Tsuchiya, Jun;
Sato, Ayako;
Tsunoda, Tomoyuki;
Miyoshi, Masato;
Nitta, Sayuri;
Kawai‐Kitahata, Fukiko;
Itsui, Yasuhiro;
Azuma, Seishin;
Kakinuma, Sei;
Murata, Kazumoto;
Mizokami, Masashi;
Watanabe, Mamoru

Publication type:

Article

Portal hypertension in hepatitis B‐related cirrhosis: Diagnostic accuracy of liver and spleen stiffness by 2‐D shear‐wave elastography.

Published in:

Hepatology Research, 2019, v. 49, n. 5, p. 540, doi. 10.1111/hepr.13306

By:

Zhu, Yu‐li;
Ding, Hong;
Fu, Tian‐tian;
Peng, Shi‐yun;
Chen, Shi‐yao;
Luo, Jian‐jun;
Wang, Wen‐ping

Publication type:

Article

Efficacy and safety of repeated use of lusutrombopag prior to radiofrequency ablation in patients with recurrent hepatocellular carcinoma and thrombocytopenia.

Published in:

Hepatology Research, 2019, v. 49, n. 5, p. 590, doi. 10.1111/hepr.13305

By:

Ishikawa, Toru;
Okoshi, Marina;
Tomiyoshi, Kei;
Kojima, Yuichi;
Horigome, Ryoko;
Imai, Michitaka;
Nozawa, Yujiro;
Iwanaga, Akito;
Sano, Tomoe;
Honma, Terasu;
Yoshida, Toshiaki

Publication type:

Article

Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non‐alcoholic fatty liver disease complicated by diabetes mellitus.

Published in:

Hepatology Research, 2019, v. 49, n. 5, p. 531, doi. 10.1111/hepr.13304

By:

Akuta, Norio;
Kawamura, Yusuke;
Watanabe, Chizuru;
Nishimura, Akihiro;
Okubo, Minoru;
Mori, Yasumichi;
Fujiyama, Shunichiro;
Sezaki, Hitomi;
Hosaka, Tetsuya;
Kobayashi, Masahiro;
Kobayashi, Mariko;
Saitoh, Satoshi;
Suzuki, Fumitaka;
Suzuki, Yoshiyuki;
Arase, Yasuji;
Ikeda, Kenji;
Kumada, Hiromitsu

Publication type:

Article

Long‐term antitumor effect of lenvatinib on unresectable hepatocellular carcinoma with portal vein invasion.

Published in:

Hepatology Research, 2019, v. 49, n. 5, p. 594, doi. 10.1111/hepr.13294

By:

Takeda, Haruhiko;
Nishijima, Norihiro;
Nasu, Akihiro;
Komekado, Hideyuki;
Kita, Ryuichi;
Kimura, Toru;
Kudo, Masatoshi;
Osaki, Yukio

Publication type:

Article